Clinical Trial Update: SAfety of Regional Citrate Anticoagulation (SARCA Study) [Phase 3]

View source ↗

Summary

Phase 3 SARCA study evaluating the safety of regional citrate anticoagulation in acute kidney injury and end-stage renal disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Injury

Snippet

Sponsor: Fresenius Medical Care North America | Conditions: Acute Kidney Injury, ESRD | Phase 3 | Status: RECRUITING